Company intelligence / Profile preview

Avir Pharma

Canada

Ownership: Private
Development stage: Other

Overview

Avir Pharma commercializes and distributes innovative and specialty pharmaceutical products in Canada, including approved drugs for osteoporosis, coronary artery disease, actinic keratosis, ulcerative proctitis, and community-acquired pneumonia, among others. Several products have regulatory approval and are available on the market in Canada or the US.

Therapeutic areas: EndocrinologyInfectious DiseasesGastroenterologyDermatologyCardiovascular
Modalities: Small moleculeRecombinant polypeptideSynthetic peptide
Industry: Biotech

Beyond the preview

Go deeper on Avir Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avir Pharma.

Explore the full profile